Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

A novel translocation t(3;21)(p21;q22) in acute myelogenous leukemia preceding a late-appearing Philadelphia chromosome

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Kurzrock R, Bueso-Ramos CE, Kantarjian H, Freireich E, Tucker SL, Siciliano M et al. BCR rearrangement-negative chronic myelogenous leukemia revisited. J Clin Oncol 2001; 19: 2915–2926.

    Article  CAS  Google Scholar 

  2. Jacobsen RJ, Himoe E, Sacher RA, Shashaty GG . Late appearance of Philadelphia chromosome. Br J Haematol 1986; 63: 312–314.

    Google Scholar 

  3. Deininger M, Buchdunger E, Druker BJ . The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 2005; 105: 2640–2653.

    Article  CAS  Google Scholar 

  4. Paietta E, Racevskis J, Bennett JM, Neuberg D, Cassileth PA, Rowe JM et al. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia 1998; 12: 1881–1885.

    Article  CAS  Google Scholar 

  5. Catovsky D . Ph-positive acute leukaemia and chronic granulocytic leukaemia: one or two diseases? Br J Haematol 1979; 42: 493–498.

    Article  CAS  Google Scholar 

  6. Shi G, Weh HJ, Martensen S, Seeger D, Hossfeld DK . 3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia. Cytogenet Cell Genet 1996; 74: 295–299.

    Article  CAS  Google Scholar 

  7. Pedersen-Bjergaard J, Brondum-Nielsen K, Karle H, Johansson B . Chemotherapy-related – late occurring – Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors? Leukemia 1997; 11: 1571–1574.

    Article  CAS  Google Scholar 

  8. Jentsch-Ullrich K, Pelz AF, Braun H, Koenigsmann M, Mohren M, Wieacker P et al. Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinib. Haematologica 2004; 89: ECR15.

    PubMed  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the assistance of Ms Kimberly Hayes and Ms Joanne Cheng.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Verstovsek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quintás-Cardama, A., Abruzzo, L., Giles, F. et al. A novel translocation t(3;21)(p21;q22) in acute myelogenous leukemia preceding a late-appearing Philadelphia chromosome. Leukemia 20, 1638–1640 (2006). https://doi.org/10.1038/sj.leu.2404283

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404283

This article is cited by

Search

Quick links